AS
IART icon

Altshuler Shaham’s Integra LifeSciences IART Stock Holding History

Altshuler Shaham’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-476
Closed -$26K – 494
2022
Q2 		$26K Buy
+476
New +$28.6K ﹤0.01% 361
2021
Q3 		– Sell
-615
Closed -$42K – 580
2021
Q2 		$42K Buy
615
+37
+6% +$2.62K ﹤0.01% 472
2021
Q1 		$40K Buy
+578
New +$39.2K ﹤0.01% 323
2019
Q4 		– Sell
-160
Closed -$9K – 555
2019
Q3 		$9K Buy
+160
New +$9.53K ﹤0.01% 297

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Altshuler Shaham's IART Position: Q3 2022 in Review

Altshuler Shaham sold out of Integra LifeSciences (IART) in Q3 2022, closing a stake of 476 shares — an estimated $26K sold.

Altshuler Shaham first reported a position in IART in Q3 2019 and held it in 4 quarters. The position peaked at $42K in Q2 2021. 282 funds tracked by Wall St. Rank hold IART as of Q3 2022.

  • Altshuler Shaham reported no remaining Integra LifeSciences position as of Q3 2022 after selling out during the quarter.
  • Altshuler Shaham sold 476 Integra LifeSciences shares in Q3 2022, an estimated $26K.
  • Altshuler Shaham first reported a position in Integra LifeSciences in Q3 2019 and held it in 4 quarters.
  • Altshuler Shaham's Integra LifeSciences position peaked at $42K in Q2 2021.
  • 282 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2022.

Based on Altshuler Shaham's 13F filing for Q3 2022, filed 14 Nov 2022.